03 SEP 2010 05:51 BREAST ACCRUAL REPORT - OPEN and recently closed STUDIES
REGS. REGS. REGS. REGS. REGS.
R LAST LAST LAST LAST LAST # of # of
E ACCR. TOTAL 12 6 3 30 7 ACT. CURR
STUDY G ARM GOAL REGS. Month Month Month DAYS DAYS INSTs IRBs
-------------------------------------- - --------------------------------- ----- ----- ----- ----- ----- ----- ----- ----- -----
JMA20-Breast, Early, Regional RT 1 Total Registrations 8 0 0 0 0 0
----- ----- ----- ----- ----- -----
8 0 0 0 0 0
JMA27B-5yr Adj Anast vs Exemestrane 1 Total Registrations 94 0 0 0 0 0 127 39
----- ----- ----- ----- ----- -----
94 0 0 0 0 0
N0434-JMA27 Companion Study 1 Total Registrations 100 0 0 0 0 0
----- ----- ----- ----- ----- -----
100 0 0 0 0 0
N063D-ALTTO 1 Total Registrations 80 50 34 16 6 1 277 134
----- ----- ----- ----- ----- -----
80 50 34 16 6 1
N0733-Her2+, Cap + Lap +/- IMC-A12 1 Total Registrations 2 2 2 0 0 0 131 60
----- ----- ----- ----- ----- -----
2 2 2 0 0 0
PACCT-1-Assess of Ca Clinical Tests 1 Total Registrations 1700 444 218 115 46 5 452 272
----- ----- ----- ----- ----- -----
1700 444 218 115 46 5
Z1071-Node+, chemo + LN dissect 1 Total Registrations 15 15 13 5 3 1
----- ----- ----- ----- ----- -----
15 15 13 5 3 1
33 rows selected.
03 SEP 2010 05:51 BREAST Open Studies with No Registrations
Study Registration/Phase Open Date
---------------------------------------- ----------------------------------- ---------
C40603 Carb/Bev+Neoadj Pac, then AC/EC 1 Endorsed Study 21-May-10
MA.32 Metformn vs Placebo 1 Endorsed Study 08-Jul-10
2 rows selected.
no rows selected
03 SEP 2010 05:51 page 1
BREAST SEGMENT ACCRUAL REPORT - OPEN and recently closed STUDIES
R
E TOTAL
STUDY G ARM SEGMENT REGS.
-------------------------------------- - --------------------------------- ----------------------------------- -----
S0221-Breast,Adj,N+,ACvAC+G/Pac q1v2 1 1 AC+PEG-Gx6 then q2wk T+PEG-Gx6 01: AC x 6 669
1 AC+PEG-Gx6 then q2wk T+PEG-Gx6 02: q 2wk Taxol + PEG-G 543
2 AC+Gx15wks then q2wk T+PEG-Gx6 01: AC+G 687
2 AC+Gx15wks then q2wk T+PEG-Gx6 02: q 2wk Taxol + PEG-G 530
3 AC+PEG-Gx6 then weekly T x 12 01: AC x 6 686
3 AC+PEG-Gx6 then weekly T x 12 02: weekly Taxol 575
4 AC+Gx15wks then weekly T x 12 01: AC+G 638
4 AC+Gx15wks then weekly T x 12 02: weekly Taxol 502
S0500-Brst,Adv,CTC,mntain v chnge tx 1 1 Initial screening blood draw 01: Registration to 3 weeks 15
1 Initial screening blood draw 02: 3-6 weeks 2
1 Initial screening blood draw 03: 6 weeks onward 2
2 < 5 CTC, Arm A (Low Risk) 01: Registration to 3 weeks 200
2 < 5 CTC, Arm A (Low Risk) 02: 3-6 weeks 11
2 < 5 CTC, Arm A (Low Risk) 03: 6 weeks onward 7
3 >= 5 CTC, re-reg required 01: Registration to 3 weeks 28
3 >= 5 CTC, re-reg required 02: 3-6 weeks 5
3 >= 5 CTC, re-reg required 03: 6 weeks onward 1
4 Maintain current therapy 01: Registration to 3 weeks 154
4 Maintain current therapy 02: 3-6 weeks 119
4 Maintain current therapy 03: 6 weeks onward 114
5 Switch therapy 01: Registration to 3 weeks 40
5 Switch therapy 02: 3-6 weeks 28
5 Switch therapy 03: 6 weeks onward 25
2 6 Maintain current therapy 01: Registration to 3 weeks 38
7 Switch therapy 01: Registration to 3 weeks 39
S0800-Brst,Neoadj nabPAC+/-Bev->AC+G 1 1 Nab-PAC + BEV -> AC+PEG-G 01: Bevacizumab + nab-paclitaxel 5
2 Nab-PAC -> AC + PEG-G 01: Nab-paclitaxel 3
3 AC + PEG-G -> Nab-PAC 01: AC + PEG-G 4
28 rows selected.
SWOG StatCtr Home Page
1 row selected.